EVALUATION OF ANTIBACTERIAL ACTIVITY OF PENTABARK KASHAYA AGAINST SELECTED BACTERIAL STRAINS CAUSING WOUND INFECTION: IN-VITRO STUDY
HTML Full TextEVALUATION OF ANTIBACTERIAL ACTIVITY OF PENTABARK KASHAYA AGAINST SELECTED BACTERIAL STRAINS CAUSING WOUND INFECTION: IN-VITRO STUDY
Manjula Mandiwalar * 1, S. Shindhe Pradeep 1, Rudramma Rachayya Hiremath 2 and Ramesh Killedar 1
Department of Shalya Tantra 1, Department of Agad Tantra (Ayurvedic Forensic Medicine & Toxicology) 2, KAHER’S Shri B. M. Kankanawadi Ayurveda Mahavidhyalaya Shahapur, Belagavi - 590005, Karnataka, India.
ABSTRACT: Background: Wound infection occurs when one or more organisms invade the wound. Nosocomial infections are the most common hospital acquired infections responsible for mortality and morbidity. Multidrug resistance against bacterial strains is the most serious emerging situation in worldwide, warranting the search for other alternatives. In this regard Pentabark kashaya was developed which contains ingredients possessing antimicrobial, anti inflammatory, and wound healing activity. Materials and Methods: Antibacterial activity of Pentabarkkashaya (PK) was determined against three predominant bacterial strains one gram positive and two gram negative strain Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. The sensitivity of the organisms were tested by both the agar well method and broth dilution method (MIC) and it was compared with the antibacterial activity of provide iodine solution 5%. Result: Pentabark kashaya showed antibacterial activity against all the test pathogens in both agar well and broth dilution method. The highest antimicrobial activity was observed against Escherichia coli and Pseudomonas aeruginosa in agar well diffusion method showed the inhibitory zone of 14 mm in both organisms. Conclusion: Pentabark kashaya has antibacterial property against all the test organisms.
Keywords: |
Antibacterial activity, Pentabark kashaya, Wound infection, Agar well method
INTRODUCTION: Wound infection is one of the most common and serious complications among the hospital acquired infections. It can increase the length of hospital stay and accounts for the mortality rate up to 70–80% 1. In wounds, identifying and managing infection is an important aspect of primary care practice. Topical wounds require special attention as they are more prone for bacterial, fungal, and viral contaminations, thereby making them further susceptible to other types of secondary complications 2.
Bacterial infections are serious problems to the successful treatment of the wounds resulting in the complications sometimes leading to fatal sepsis 3.
The common bacterial pathogens responsible for wound infections are Staphylococcus aureus, Pseudomona aeruginosa, and bacteria belonging to family Enterobacteriaceae 4. These pathogens can seriously delay wound healing process by disrupting the normal clotting mechanisms and promoting disordered leukocyte function and poor quality granulation tissue formation, reduce tensile strength of connective tissue, and impair epithelization 5. The emergence and spread of multidrug-resistant (MDR) bacterial pathogens have substantially threatened the current anti-bacterial therapy 6. The pharmaceutical industries have produced a number of new antibiotics but resistance to these drugs by microorganisms has increased as bacteria has the genetic ability to transmit and acquire resistance to synthetic drugs that are utilized as therapeutic agents 7. So, it is necessary to develop new drugs to control pathogenic microorganism. Ayurveda has described numerous medicinal plants and formulations which have wound healing, antibacterial, antifungal, and antiprotozoal effect that could be used either systemically or locally. Now a days medicinal property of plants have also been preferred throughout the world, due to their potent pharmaco-logical activities, low toxicity, and economic viability, when compared with synthetic drugs. Medicinal plants are rich in a wide varietyof bioactive secondary metabolites such as tannins, terpenpoids, alkaloids, saponins, flavonoids, and phenolic compounds that can produce a definite physiological action on the human body and helps in control of wound infection 8. The ingredients of Pentabark kashaya are Vata (Ficus bengalensis Linn), Udumbara (Ficus racemosa Linn), Ashwatha (Ficus religiosa Linn), Parish (Thesposia populnea Soland.), Plaksha (Ficus infectoria Roxb), Kasisa (Ferrous Sulphate (FeSO47H2O), Tuttha (Copper Sulphate (CuSO47H2O), and Spatika (Potash Alum (K2SO4Al2SO4)324H2O) are having the antimicrobial, anti-inflammatory wound healing properties. In the present study antibacterial activity of Pentabark kashaya was evaluated against three predominant bacterial strains one gram-positive and two gram-negative strain Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa.
MATERIALS AND METHODS:
Source of Raw Drugs: Vata (Ficus bengalensis Linn), Udumbara (Ficus racemosa Linn), Ashwatha (Ficus religiosa Linn), Parish (Thesposia populnea Soland.), Plaksha (Ficus infectoria Roxb), Kasisa (Ferrous Sulphate (FeSO47H2O)), Tuttha (Copper Sulphate (CuSO47H2O)), and Spatika(Potash Alum (K2SO4Al2SO4)324H2O)) were procured from the GMP certified KLE Ayurved Pharmacy, Belagavi and authenticated at central research facility, Ayush approved drug testing laboratory of KAHER’s Shri B.M.K Ayurveda Mahavidyalaya, Belagavi.
Preparation of Pentabark Kashaya: 9 Preparation of Pentabark kashaya was done in Rasashastra and Bhaishajya Kalpana department, KAHER’s Shri B.M.K Ayurveda Mahavidyalaya, Belagavi.
TABLE 1: SHOWING INGREDIENTS OF 100 ML PENTABARK KASHAYA
S. no. | Name of Drug | Latin Name | Part used | Quantity |
1 | Vata | Ficus bengalensis Linn. | Bark | 10gm |
2 | Udumbara | Ficus racemosa Linn. | Bark | 10gm |
3 | Ashwatha | Ficus religiosa Linn. | Bark | 10gm |
4 | Parisha | Thesposia populnea Soland. | Bark | 10gm |
5 | Plaksha | Ficus infectoria Roxb. | Bark | 10gm |
6 | ShodhitaKasisa | Ferrous Sulphate (FeSO47H2O) | 1gm* | |
7 | ShodhitaTutta | Copper Sulphate (CuSO47H2O) | 25mg* | |
8 | ShodhitaSpatika | Potash Alum (K2SO4Al2SO4)324H2O) | 2.75 mg* | |
9 | Sodium benzoate | 10mg | ||
10 | Methyl paraben | 100mg |
*Note - Selection of quantity of Shodhita Tutta (0.012%), Kasisa (0.5 to 1 %) and Spatika (1 to 10%) was made on the basis of text book inorganic pharmaceutical Chemistry by Bently and Indian Pharmacopoeia.
Method of Preparation: Panchavalkala (Vata, Udumber, Ashwatha, Parisha, Plaksha) Kashaya 100ml was prepared as per standard operative procedure. Prepared Kashaya (Decoction) was taken in a steel vessel and it was mixed with Shodhita Kasisa, Shodhita Tutta, and Shodhita Spatika as quantity mentioned. Preservatives, Sodium benzoate and Methyl paraben were added individually and stirred well till they completely dissolved. Kashaya (Decoction) was filtered and stored in bottle.
Antibacterial Study: Antibacterial study was done in microbiology department of Mararha Mandal’s Nathajirao G. Halgekar Institute of Dental Sciences and Research Centre Belgavi.
Selection of Pathogens for the Study: Antibacterial activity of Pentabark kashaya was determined against three predominant bacterial strains one gram-positive and two gram-negative strain Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa.
TABLE 2: SHOWING THE ATCC NO OF MICRO-ORGANISM
S. no. | Micro- organism | Standard ATCC No. |
1 | Staphylococcus aureus (Gram +ve) | ATCC No.12598 |
2 | Escherichia coli
(Gram –ve) |
ATCC No.25922 |
3 | Pseudomonas aeruginosa (Gram –ve ) | ATCC No.25619 |
Inoculums Preparation: Brain heart infusion broth medium was prepared by adding brain heart infusion broth into distilled water and sterilized in an autoclave. Using a loop or swab, colonies were inoculated to the broth. Visually turbidity of broth was adjusted to equal that of a 0.5 McFarland turbidity standard that has been vortexed. Alternatively, the suspension was standardized with a photometric device.
Antibacterial Activity by Agar Well Method:
Inoculation of Agar Plate: Brain infusion agar plate was prepared. Within 15 min of adjusting the inoculums to a McFarland 0.5 turbidity standard, a sterile cotton swab was dipped into the inoculums and rotated it against the wall of the tube above the liquid to remove excess inoculums. Entire surface of agar plate was swabbed three times, rotating plates approximately 60º between streaking to ensure even distribution. Inoculated plate was allowed to stand for at least 3 min but no longer than 15 min before making wells. Hollow tube of 5mm diameter was taken, heated it. Press it on an inoculated agar plate to make a well in the plate. Likewise, five wells on each plate was made. With the help of micropipette 75µl, 50 µl, 25 µl, 10 µl and 5 µl of compound was added into the respective wells on each plate Fig. 1, 2, 3.
FIG. 1: ANTIBACTERIAL ACTIVITY AGAINST S. AUREUS
FIG. 2: ANTIBACTERIAL ACTIVITY AGAINST E. COLI
FIG. 3: ANTIMICROBIAL ACTIVITY AGAINST PSEUDOMONAS AERUGINOSA
Incubate the plates for 18-24 h at 37 ºC in incubator. Measure the diameter of inhibition zone to the nearest whole mile meter by holding the measuring device.
Antibacterial Activity by Broth Dilution Method (MIC): 9 dilutions of each drug have to be done with BHI for MIC. In the initial tube 20 microliter of drug was added into the 380 microliter of BHI broth. For dilutions 200 microliter of BHI broth was added into the next 9 tubes separately. Then from the initial tube 200 microliter was transferred to the first tube containing 200 microliter of BHI broth. This was considered as 10-1 dilution. From 10-1 diluted tube 200 microliter was transferred to second tube to make 10-2 dilution. The serial dilution was repeated up to 10-9 dilution for each drug. From the maintained stock cultures of required organisms, 5microliter was taken and added into 2ml of BHI (brain heart infusion) broth. In each serially diluted tube 200 microliter of above culture suspension was added Fig. 4, 5. The tubes were incubated for 24 h and observed for turbidity.
FIG. 4: MIC OF PENTABARK KASHAYA
FIG. 5: MIC OF POVIDONE IODINE SOLUTION
OBSERVATION AND RESULTS: Pentabark kashaya shows antibacterial activity against all the test pathogens in both agar well and broth dilution method.
TABLE 3: SHOWING ZONE OF INHIBITION OF PENTABARK KASHAYA AND POVIDONE IODINE SOLUTION IN AGAR WELL METHOD
S. no. | Samples | 75 µg/ml | 50 µg/ml | 25 µg/ml | 10 µg/ml | 5 µg/ml |
P. aerugenosa | ||||||
1 | Panchavalkaladi Kashaya | 14mm | 12mm | 10mm | R | R |
2 | Povidone Iodine | 10mm | 08mm | R | R | R |
S. aureus | ||||||
1 | Panchavalkaladi Kashaya | 12mm | 10mm | R | R | R |
2 | Povidone Iodine | 17mm | 15mm | 13mm | R | R |
E. coli | ||||||
1 | Panchavalkaladi Kashaya | 14mm | 11mm | 10mm | R | R |
2 | Povidone Iodine | 13mm | 10mm | R | R | R |
Observation: S – Sensitive R – Resistant |
Pentabark kashaya showed zone of inhibition of 10mm at 50µg/ml and 12mm at 75µg/ml dilutions against S. aureus whereas povidone iodine shows 13mm at 25µg/ml, 15mm at 50µg/ml and 17mm at 75µg/ml dilutions. Pentabark kashaya showed zone of inhibition of 10mm at 25µg/ml, 11mm at 50µg/ml and 14mm at 75µg/ml dilutions against E. coli whereas povidone iodine shows 10mm at 50µg/ml and 13mm at 75µg/ml dilutions. Pentabark kashaya showed zone of inhibition of 10mm at 25µg/ml, 12mm at 50µg/ml and 14mm at 75µg/ml dilutions against Pseudomonas whereas povidone iodine shows 8mm at 50µg/ml and 10mm at 75µg/ml dilutions. Povidone iodine was resistant at 25µg/ml dilution.
TABLE 4: SHOWING OBSERVATION OF MIC OF PENTABARK KASHAYA AND POVIDONE IODINE SOLUTION
S. no. | Samples | 100 µg/ml | 50 µg/ml | 25 µg/ml | 12.5 µg/ml | 6.25 µg/ml | 3.12 µg/ml | 1.6 µg/ml | 0.8 µg/ml | 0.4 µg/ml | 0.2 µg/ml |
E. coli | |||||||||||
1 | Panchavalkaladi Kashaya | S | S | S | S | S | S | R | R | R | R |
2 | Povidone Iodine | S | R | R | R | R | R | R | R | R | R |
S. aureus | |||||||||||
1 | PanchavalkaladiKashaya | S | S | S | S | S | S | S | S | R | R |
2 | Povidone Iodine | S | R | R | R | R | R | R | R | R | R |
P. aerugenosa | |||||||||||
1 | PanchavalkaladiKashaya | S | S | R | R | R | R | R | R | R | R |
2 | Povidone Iodine | S | R | R | R | R | R | R | R | R | R |
Observation: S – Sensitive R – Resistant |
TABLE 5: SHOWING DISC DIFFUSION RESULT OF PENTABARK KASHAYA
S. no. | Organism | Standard | Povidone iodine | Pentabark kashaya |
1 | Staphylococcus aureus
(Gram +ve) |
26mm at 2µg/ml | 13mm at 25µg/ml
15mm at 50µg/ml 17mm at 75µg/ml |
10mm at 50µg/ml
12mm at 75µg/ml |
2 | Escherichia coli (Gram –ve) | 32mm at 2µg/ml | 10m at 50µg/ml
13mm at 75µg/ml |
10mm at 25µg/ml
11mm at 50µg/ml 14mm at 75µg/ml |
3 | Pseudomonas (Gram –ve ) | >21mm at 2µg/ml | 08mm at 50µg/ml
10mm at 75µg/ml |
10mm at 25µg/ml
12mm at 50µg/ml 14mm at 75µg/ml |
TABLE 6: SHOWING MIC RESULT OF PENTABARK KASHAYA
S. no. | Organism | Standard | Povidone iodine | Pentabark kashaya |
1 | Staphylococcus aureus (Gram +ve) | 2µg/ml | 100 µg/ml | 0.8 µg/ml |
2 | Escherichia coli (Gram –ve) | 2µg/ml | 100 µg/ml | 3.12 µg/ml |
3 | Pseudomonas (Gram –ve ) | <4µg/ml | 100 µg/ml | 50 µg/ml |
The minimum inhibitory concentration (MIC) of Pentabark kashaya against E. coli, S. areus and Pseudomonas was 3.12µg/ml, 0.8µg/ml and 50µg/ml respectively whereas MIC of Povidone iodine was 100µg/ml in all test organisms.
DISCUSSION: Wound infections cause economic burden to the patients and also increases the hospital stay. Multidrug resistance against human pathogensis an emerging serious condition. Due to a high incidence of antibiotic resistance, evaluating the antibacterial effect of herbal medicines as potent agents for treating wound infections has a paramount importance. in addressing animal as well as human health problems 10.
In the present study Pentabark kashaya was evaluated for its antibacterial property against both gram negative and gram positive micro organisms. The results were compared with the antibacterial activity of povidon iodine 5% solution.
Pentabark kashaya showed maximum zone of inhibition of 14mm for Pseudomonas and E. coli organism and minimum zone of inhibition of 12mm for S. aureus. Povidon iodine showed maximum zone of inhibition of 17mm for S. aureus and 13mm for E. coli and minimum zone of inhibition of 10mm for Pseudomonas Table 5. This reveals that Pentabark kashaya was more active against Pseudomonas and E. coli.
The minimum inhibitory concentration (MIC) of Pentabark kashaya was 0.8µg/ml, 3.12µg/ml, and 50µg/ml against S. areus, E. coli and Pseudomonas respectively whereas Povidone iodine had MIC of 100µg/ml against all the three microorganisms Table 6. This result shows that Pentabark kashaya has anti-bacterial activity against all the three organisms more on S. aureus.
Pentabark kashaya has shown antibacterial activity against all the three test organisms’ i.e. E. coli, S. aureus, Pseudomonas in both methods, this may be because of antimicrobial activity of Panchavalkala (five barks), Kasisa (Ferrous Sulphate (FeSO47H2O)), Tuttha (Copper Sulphate (CuSO47H2O)). As formulation contains tannins, alkaloids, saponins as a phytochemicals 11 which are known to have anti-inflammatory, astringent, and antimicrobial activities 12. Shodhita Tutta (Copper Sulphate) has antibacterial activity on E. coli, S. aureus bacteria and antifungal activity on fungi Candida albicans 13. Spatika (Potash alum) has bacteriostatic action with MIC of 2% conc. 14
CONCLUSION: In-vitro antibacterial study showed Pentabark kashaya has antibacterial activity against all the three test organisms S. aureus, E. coli and Pseudomonas aeruginosa. So, this formulation can be used in wound management as an alternative medicine.
ACKNOWLEDGEMENT: Dr B. S. Prasad, Director, KLE Ayurved Pharmacy, Khasbag Belagavi for financial support to complete the research study.
CONFLICTS OF INTEREST: No competing financial interests exist.
REFERENCES:
- Haque M, Sartelli M, McKimm J and Abu Bakar M: Health care-associated infections - an overview. Infect Drug Resist. 2018; 11: 2321-33.
- Negut I, Grumezescu V and Grumezescu AM: Treatment Strategies for Infected Wounds. Mol 2018; 23(9): 2392.
- Rahim K, Saleha S, Zhu X, Huo L, Basit A and Franco OL: Bacterial contribution in chronicity of wounds. Microb Ecology 2017; 73: 710-21.
- Rai S, Yadav UN, Pant ND, Yakha JK, Tripathi PP, Poudel A and Lekhak B: Bacteriological profile and antimicrobial susceptibility patterns of bacteria isolated from pus/wound swab samples from children attending a tertiary care hospital in Kathmandu, Nepal. International Journal of Microbiology 2017; 5.
- Landén NX, Li D and Ståhle M: Transition from inflammation to proliferation: a critical step during wound healing. Cell Mol Life Sci 2016; 73(20): 3861-85.
- Frieri M, Kumar K and Boutin A: Antibiotic resistance. J of Infection and Public Health 2017; 10(4): 369-78.
- Aslam B, Wang W, Arshad MI, Khurshid M, Muzammil S, Rasool MH, Nisar MA, Alvi RF, Aslam MA, Qamar MU, Salamat M and Baloch Z: Antibiotic resistance: a rundown of a global crisis. Infect Drug Resist 2018; 11: 1645-58.
- Tungmunnithum D, Thongboonyou A, Pholboon A and Yangsabai A: Flavonoids and other phenolic compounds from medicinal plants for pharmaceutical and medical aspects: an overview. Medicines (Basel) 2018; 5(3): 93.
- Manjula M, Shindhe PS and Hiremath RR: Development and phytochemical evaluation of Panchavalkaladi kashaya: a polyherbomineral formulation. Indian Journal of Ancient Medicine and Yoga 2016; 9(3): 85-89.
- Vadhana P, Singh BR, Bharadwaj M and Singh SV: Emergence of herbal antimicrobial drug resistance in clinical bacterial isolates. Pharm Anal Acta 2015; 6: 434.
- Manjula M, Shindhe PS and Hiremath RR: Development and phytochemical evaluation of Panchavalkaladi kashaya: a polyherbomineral formulation. Indian Journal of Ancient Medicine and Yoga 2016; 9(3): 85-89.
- Wintola OA and Afolayan AJ: The antibacterial, phytochemicals and antioxidants evaluation of the root extracts of Hydnora africana used as antidysenteric in Eastern Cape Province, South Africa. BMC Complement Altern Med 2015; 15: 307.
- Mahmoodi S, Elmi A and Hallaj-Nezhadi S: Copper nanoparticles as antibacterial agents. J Mol Pharm Org Process Res 2018; 6: 140.
- Amadi LO: A review of antimicrobial properties of alum and sundry applications. Acta Scientific Microbiology 2020; 3(4): 109-17.
How to cite this article:
Mandiwalar M, Pradeep SS, Hiremath RR and Killedar R: Evaluation of antibacterial activity of Pentabark kashaya against selected bacterial strains causing wound infection: in-vitro study. Int J Pharm Sci & Res 2021; 12(7): 3687-92. doi: 10.13040/IJPSR.0975-8232. 12(7).3687-92.
All © 2013 are reserved by the International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
Article Information
17
3687-3692
635
757
English
IJPSR
M. Mandiwalar *, S. S. Pradeep, R. R. Hiremath and R. Killedar
Department of Shalya Tantra, KAHER’S Shri B. M. Kankanawadi Ayurveda Mahavidhyalaya Shahapur, Belagavi, Karnataka, India.
manjulamadiwalar@gmail.com
18 October 2019
04 February 2020
04 March 2020
10.13040/IJPSR.0975-8232.12(7).3687-92
01 July 2021